Trials / Sponsors / Australasian Leukaemia and Lymphoma Group
Australasian Leukaemia and Lymphoma Group
Academic / Other · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | 2023-12-11 |
| Recruiting | A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Expo Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory | Phase 2 | 2023-10-12 |
| Completed | Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Chronic Myeloid Leukaemia | Phase 2 | 2014-04-11 |
| Withdrawn | Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP Lymphoma, Non-Hodgkin | N/A | 2012-01-01 |